JACOBS LEVY EQUITY MANAGEMENT, INC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$5,220,565
-41.5%
505,379
-25.7%
0.03%
-39.2%
Q2 2023$8,921,945
+22.3%
680,545
+4.3%
0.05%
+13.3%
Q1 2023$7,296,169
+187.5%
652,609
+116.8%
0.04%
+164.7%
Q4 2022$2,538,130301,0830.02%
Other shareholders
PULMONX CORP shareholders Q4 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders